D-Chiro-Inositol

Othervitamin-likeLimited dose evidence

Also known as: DCI, D-chiro inositol, chiro-inositol, D-chiroinositol

Add to a formula

D-chiro-inositol is a minor inositol isomer produced from myo-inositol by an insulin-dependent epimerase. It is involved in insulin signaling for glycogen synthesis and in ovarian steroid handling, and it is used almost exclusively in women's hormone and metabolic formulas, most often as the minor partner in a 40:1 myo-inositol to D-chiro-inositol blend that mirrors the plasma ratio. Reviews caution that high D-chiro-inositol alone may work against ovarian function, so doses are kept in the low hundreds of milligrams.

Research summary

Incorporated into inositol phosphoglycan mediators that activate glycogen synthase and pyruvate dehydrogenase downstream of the insulin receptor; modulates aromatase and androgen synthesis in the ovary.

Dosage

Daily amounts, of compound.

Lowest studiedTypical rangeHighest studiedUpper limit
100–600 mg

Doses are mg D-chiro-inositol. In the ratio study by Nordio 2019, 4 g/day of combined inositols at 40:1 delivers about 100 mg/day D-chiro-inositol, the ratio that performed best for ovulation; ratios with more D-chiro-inositol performed worse. Stand-alone products of several hundred milligrams exist, but the 600 mg ceiling here reflects market practice rather than a verified dose-finding trial, and no dose_max_studied is set. Usually taken with myo-inositol, split across the day. No UL.

Standardization: ≥98% D-chiro-inositol

Source material: carob pod extraction or conversion from myo-inositol

Forms of Inositol

FormTypical doseElement %FormatsPrice
D-Chiro-Inositol100–600 mgCapsule, Powder, Tablethigh
Myo-Inositol2–4 gPowder, Capsule, Tabletlow

Format suitability

  • Capsule
  • Powder
  • Tablet
  • Softgel
  • Gummy
  • Liquid

Water-soluble and mildly sweet; small doses fit easily in capsules or blended powders.

Formulation notes

Almost always formulated with myo-inositol at 40:1. Reviews advise against high stand-alone doses in PCOS formulas because of possible negative effects on ovarian function.

Sources

  1. The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios. (Nordio M, 2019)PubMed
  2. D-Chiro-inositol and PCOS: between myth and reality. The never-ending story. (Cianci A, 2022)PubMed
  3. Myo-inositol vs. D-chiro inositol in PCOS treatment. (Formuso C, 2015)PubMed

Related ingredients